Clinical Trial Update: ZD 1839 Plus Combination Chemotherapy in Treating Patients With Locally Advanced, Locally Recurrent, or Metastatic Colorectal Cancer [Phase 1]

View source ↗

Summary

Phase 1 study evaluating ZD 1839 (gefitinib) in combination with chemotherapy for locally advanced, locally recurrent, or metastatic colorectal cancer has compl…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Colorectal Cancer

Drugs mentioned

• Gefitinib (Gefitinib)

Snippet

Sponsor: National Cancer Institute (NCI) | Conditions: Colorectal Cancer | Phase 1 | Status: COMPLETED